Eda DOKUMACIOĞLU, Güler YENİCE, İsmail BOLAT, Hatice İSKENDER, Armağan HAYIRLI, Kübra Asena TERİM KAPAKİN, Behzat MOKTHARE

Effect of betulinic acid administration on TLR-9/NF-κB /IL-18 levels in experimental liver injury

Background/aim: Acetaminophen (APAP), used in the composition of thousands of preparations, is the most commonly used analgesic and antipyretic drug. The present study aimed to investigate the potential protective effects of the betulinic acid (BA) treatment through an APAP-induced hepatotoxicity rat model, using inflammatory, biochemical, and histopathological parameters. Materials and methods: The study consisted of four groups: control group, APAP group, BA group, and APAP+BA group. Experimental studies continued for fifteen days. Serum samples were analysed for glucose, total cholesterol (TChol), triglyceride (TG), low density lipoprotein (LDL), high density lipoprotein (HDL), aspartate amino transferase (AST), malondialdehyde (MDA), toll-like receptor-9 (TLR-9), nuclear factor kappa B (NF-κB), and interleukin-18 (IL-18). Results: TLR9, IL-18, NF-κB, and MDA levels increased significantly in liver injury groups. These increases considerably decreased by the BA treatment. All groups showed immunopositivity for 8-hydroxy-2’–deoxyguanosine (8-OHdG) and interleukin (IL-1β) in the hepatocytes, inflammatory cells, and epithelial cells of bile ducts. Conclusion: BA can be used as an effective agent in the prevention and treatment of acute liver diseases due to its inhibitory properties in multiple pathways and its potent antioxidant effects.Key words: Acetaminophen, betulinic acid, interleukin-18, nuclear factor kappa B, toll-like receptor-9

PDF

___

1. Lee WM. Acetaminophen (APAP) hepatotoxicity-isn’t it time for APAP to go away. Journal of Hepatology 2017; 67: 1324-1331. doi: 10.1016/j.jhep.2017.07.005
2. Watson WA, Litovitz TL, Rodgers GC Jr, Klein-Schwartz W, Reid N et al. 2004 annual report of the American association of poison control centers toxic exposure surveillance system. American Journal of Emergency Medicine 2005; 23: 589-666. doi: 10.1016/j. ajem.2005.05.001
3. Subramanya SB, Venkataraman B, Meeran MFN, Goyal SN, Patil CR et al. Therapeutic potential of plants and plant derived phytochemicals against acetaminophen-induced liver injury. International Journal of Molecular Sciences 2018; 19: 3776. doi: 10.3390/ijms19123776
4. Ko JW, Shin JY, Kim JW, Park SH, Shin NR et al. Protective effects of diallyl disulfide against acetaminophen-induced nephrotoxicity: A possible role of CYP2E1 and NF-κB. Food and Chemical Toxicology 2017; 102: 156-165. doi: 10.1016/j. fct.2017.02.021
5. Shehu AI, Ma X, Venkataramanan R. Mechanisms of druginduced hepatotoxicity. Clinical Liver Disease 2017; 21: 35-54. doi: 10.1016/j.cld.2016.08.002
6. Browne EP. Regulation of B-cell responses by Toll-like receptors. Immunology 2012; 136: 370-379. doi: 10.1111/j.1365- 2567.2012.03587.x
7. Hua Z, Hou B. TLR signaling in B-cell development and activation. Cellular & Molecular Immunology 2013; 10: 103-106. doi: 10.1038/cmi.2012.61
8. Vidya MK, Kumar VG, Sejian V, Bagath M, Krishnan G et al. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals. International Reviews of Immunology 2018; 37: 20-36. doi: 10.1080/08830185.2017.1380200
9. Cohen P. The TLR and IL-1 signalling network at a glance. Journal of Cell Science 2014; 127 (11): 2383-2390. doi: 10.1242/jcs.149831
10. Krieg AM. Therapeutic potential of Toll like receptor 9 activation. Nature Reviews Drug Discovery 2006; 5: 471-484. doi: 10.1038/ nrd2059
11. Wawrocki S, Druszczynska M, Kowalewicz-Kulbat M, Rudnicka W. Interleukin 18 (IL-18) as a target for immune intervention. Acta Biochimica Polonica 2016; 63: 59-63. doi: 10.18388/ abp.2015_115
12. Sedimbi SK, Hägglöf T, Karlsson MC. IL-18 in inflammatory and autoimmune disease. Cell Molecular Life Science 2013; 70: 4795- 4808. doi: 10.1007/s00018-013-1425-y
13. Zhang Q, Lenardo MJ, Baltimore D. 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. Cell 2017; 168: 37-57. doi: 10.1016/j.cell.2016.12.012.
14. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nature Reviews Immunology 2002; 2: 725-734. doi: 10.1038/ nri910
15. Yadav UC, Ramana KV. Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxidative Medicine and Cellular Longevity 2013; 2013: 690545. doi: 10.1155/2013/690545.
16. Henson JB, Brown CL, Chow SC, Muir AJ. Complementary and alternative medicine use in United States adults with liver disease. Journal of Clinical Gastroenterology 2017; 51: 564-570. doi: 10.1097/MCG.0000000000000617
17. Ríos JL, Máñez S. New pharmacological opportunities for betulinic acid. Planta Medica 2018; 84: 8-19. doi: 10.1055/s-0043- 123472
18. Şener TE, Kardaş RC, Şehirli AO, Demiral EE, Yüksel M et al. The effect of betulinic acid on TNBS-induced experimental colitis. Marmara Pharmaceutical Journal 2013; 17: 52-59. doi: 10.12991/201317393
19. Nader MA, Baraka HN. Effect of betulinic acid on neutrophil recruitment and inflammatory mediator expression in lipopolysaccharide-induced lung inflammation in rats. European Journal of Pharmaceutical Sciences 2012; 46: 106-113. doi: 10.1016/j.ejps.2012.02.015
20. Dokumacıoğlu E, İskender H, Aktaş MS, Hanedan B, Dokumacıoğlu A et al. The effect of sulforaphane on oxidative stress and inflammation in rats with toxic hepatitis induced by acetaminophene. Bratislava Medical Journal 2017; 118: 453-459. doi: 10.4149/BLL_2017_088
21. Ohkawa H, Oshishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbuturic acid reaction. Analytical Biochemistry 1979; 95: 351-358. doi:10.1016/0003-2697(79)90738-3
22. Terim-Kapakin KA, Gümüş R, İmik H, Kapakin S, Sağlam YS. Effects of ascorbic and α-lipoic acid on secretion of HSP- 70 and apoptosis in liver and kidneys of broilers exposed to heat stress. Ankara Üniversitesi Veteriner Fakültesi Dergisi 2012; 59: 279-287. doi: 10.1501/Vetfak_0000002539
23. Hinson JA, Roberts DW, James LP. Mechanisms of acetaminopheninduced liver necrosis. Handbook of Experimental Pharmacology 2010; 196; 369-405. doi: 10.1007/978-3-642-00663-0_12
24. Özcelik E, Uslu S, Burukoğlu D, Musmul A. Chitosan and blueberry treatment induces arginase activity and inhibits nitric oxide production during acetaminophen-induced hepatotoxicity. Pharmacognosy Magazine 2014; 10: 217-224. doi: 10.4103/0973- 1296.133234
25. Bhadauria M. Dose-dependent hepatoprotective effect of emodin against acetaminophen-induced acute damage in rats. Experimental and Toxicologic Pathology 2010; 62: 627-635. doi: 10.1016/j.etp.2009.08.006
26. Özcelik E, Uslu S, Erkasap N, Karimi H. Protective effect of chitosan treatment against acetaminophen-induced hepatotoxicity. Kaohsiung Journal of Medical Science 2014; 30: 286-290. doi: 10.1016/j.kjms.2014.02.003
27. Basset-Ibrahim MA, Wani FA, Rahiman S. Hepatoprotective effect of olive oil and camel milk on acetaminophen-induced liver toxicity in mice. International Journal of Medical Science and Public Health 2017; 6: 186-194. doi: 10.5455/ijmsph.2017.07092016614
28. Saied NM, Hamza AA. Selenium ameliorates isotretinoininduced liver injury and dyslipidemia via antioxidant effect in rats. Toxicology Mechanisms and Methods 2014; 24: 433-437. doi: 10.3109/15376516.2014.937514
29. Aktaş O, Eskiocak S, Özgün GS, Yalçın O, Süt N. The effects of L-carnitine on acetaminophen induced hepatotoxicity in rats. Turkish Journal of Biochemistry 2013; 38: 475-482. doi: 10.5505/ tjb.2013.92063
30. Simone F. Betulinic Acid for Cancer Treatment and Prevention. International Journal of Molecular Sciences 2008; 9: 1096–1107. doi: 10.3390/ijms9061096
31. Yi J, Xia W, Wu J, Yuan L, Wu J et al. Betulinic acid prevents alcohol-induced liver damage by improving the antioxidant system in mice. Journal of Veterinary Science 2014; 15: 141-148. doi: 10.4142/jvs.2014.15.1.141
32. Fan R, Hu PC, Wang Y, Lin HY, Su K et al. Betulinic acid protects mice from cadmium chloride-induced toxicity by inhibiting cadmium-induced apoptosis in kidney and liver. Toxicology Letters 2018; 299: 56-66. doi: 10.1016/j.toxlet.2018.09.003
33. Mohan S, Gupta D. Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation. Biomedicine & Pharmacotherapy 2018; 108: 1866-1878. doi: 10.1016/j. biopha.2018.10.019
34. Luangmonkong T, Suriguga S, Mutsaers HAM, Groothuis GMM, Olinga P et al. Targeting oxidative stress for the treatment of liver fibrosis. Reviews of Physiology, Biochemistry and Pharmacology 2018; 175: 71-102. doi: 10.1007/112_2018_10
35. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. Journal of Clinical Investigation 2009; 119: 305-314. doi: 10.1172/JCI35958
36. Teratani T, Tomita K, Suzuki T, Furuhashi H, Irie R et al. Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity via TLR9 signaling. Journal of Hepatology 2017; 67: 780-790. doi: 10.1016/j. jhep.2017.05.020
37. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends in Molecular Medicine 2007; 13: 460-469. doi: 10.1016/j. molmed.2007.09.002
38. Song S, Chu L, Liang H, Chen J, Liang J et al. Protective effects of dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1/FOXO1/NF-κB signal. Frontiers in Pharmacology 2019; 10: 1030. doi: 10.3389/fphar.2019.01030
39. Zhang M, Hu X, Li S, Lu C, Li J et al. Hepatoprotective effects of ethyl pyruvate against CCl4-induced hepatic fibrosis viainhibition of TLR4/NF-kB signaling andup-regulation of MMPs/TIMPs ratio. Clinics and Research in Hepatology and Gastroenterology 2017; 42: 72-81. doi: 10.1016/j.clinre.2017.04.008
40. Srivastava SK, Yadav UC, Reddy AB, Mishra R, Saxena A et al. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chemico-Biological Interactions 2016; 254: 247. doi: 10.1016/j.cbi.2011.02.023
41. Shan S, Shen Z, Song F. Autophagy and acetaminophen-induced hepatotoxicity. Archives of Toxicology 2018; 92: 2153-2161. doi: 10.1007/s00204-018-2237-5
42. Liu Y, Bi Y, Mo C, Zeng T, Huang S et al. Betulinic acid attenuates liver fibrosis by inducing autophagy via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Journal of Natural Medicines 2019; 73: 179-189. doi: 10.1007/ s11418-018-1262-2
43. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutrition Journal 2016; 15: 71. doi: 10.1186/s12937-016-0186-5
44. Wang S, Yang Z, Xiong F, Chen C, Chao X et al. Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway. Molecular and Cellular Endocrinology 2016; 434: 135- 143. doi: 10.1016/j.mce.2016.06.019
45. Ma-On C, Sanpavat A, Whongsiri P, Suwannasin S, Hirankarn N et al. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression. Medical Oncology 2017; 34: 57. doi: 10.1007/s12032-017-091